Alpine Global Management’s Corvus Pharmaceuticals CRVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-23,282
Closed -$125K 162
2024
Q4
$125K Buy
+23,282
New +$125K 0.02% 183